Research Advance in the Development of Antimicrobial Peptides Using Deep Learning

Area of Science:

• Biotechnology and Bioinformatics
• Computational Biology
• Drug Discovery

Background:

• Antibiotic resistance is a growing global health crisis, necessitating novel therapeutic strategies.
• Antimicrobial peptides (AMPs) show promise due to broad-spectrum activity but are challenging to discover using traditional methods.
• Conventional AMP discovery relies on costly and time-consuming laboratory trials.

Purpose of the Study:

• To review the application of deep learning for predicting antimicrobial peptide (AMP) sequences.
• To highlight the advantages of AI in accelerating AMP discovery and development.
• To discuss the current progress, limitations, and challenges of deep learning in AMP prediction.

Main Methods:

• Utilizing deep learning algorithms to analyze large-scale datasets of known AMPs.
• Automated feature extraction and sequence prediction by deep learning models.
• Overview of the workflow for AI-driven AMP sequence prediction.

Main Results:

• Deep learning models demonstrate significant advantages in screening and predicting AMPs.
• AI enhances screening efficiency and reduces research and development costs.
• This approach opens new avenues for AMP research and clinical applications.

Conclusions:

• Deep learning offers a powerful and efficient alternative to traditional methods for AMP discovery.
• Continued research and development in AI for AMP prediction are crucial for addressing antibiotic resistance.
• Addressing current limitations will further unlock the potential of AI in antimicrobial drug development.